S-1799-115
Placed on Senate Legislative Calendar under General Orders. Calendar No. 419.
Sponsored by Martin Heinrich (D-NM)
What it does
This bill would amend the Energy Policy Act of 2005 to create an "Energy Technology Maturation Program" within the Department of Energy (DOE). The program would provide funding to DOE facilities — including National Laboratories and national security sites — to help move promising energy technologies from the research stage toward commercial use. Grants would be capped at $150,000 for early-stage development activities and $750,000 for projects with an identified private-sector partner.
Who benefits
DOE National Laboratories and affiliated facilities that would receive new funding streams. Small businesses, which are given priority in the grant selection process when partnering with a DOE facility. Private-sector energy companies that could gain access to federally developed technologies at reduced cost. Entrepreneurs and startups in the energy sector seeking to commercialize advanced technologies. Consumers and industries that could eventually benefit from new energy products reaching the market. Regions where DOE facilities are located, through potential economic activity from commercialization partnerships.
Who is hurt
Private energy research firms that compete with DOE-backed technologies and may face a disadvantage if federally subsidized competitors enter the market. Taxpayers who bear the cost of grants that may not result in commercially viable products. Larger businesses that are deprioritized in favor of small business applicants. Other DOE programs that could face indirect competition for existing technology transfer and commercialization funds, since the bill allows use of the existing Energy Technology Commercialization Fund.
Supporters argue
Supporters argue that the U.S. government spends billions annually on energy research at National Laboratories, yet many promising technologies stall in the gap between basic research and commercial viability — a well-documented problem known as the "valley of death." They contend this program directly addresses that gap with modest, targeted grants and a priority for small business partnerships, maximizing the return on existing federal research investments without creating a large new bureaucracy.
Opponents argue
Opponents argue that the federal government has a poor track record of picking commercially viable technologies, pointing to high-profile failures in DOE loan and grant programs. They contend that private venture capital markets already exist to bridge the research-to-commercialization gap, and that this program risks duplicating existing DOE technology transfer mechanisms — such as the existing Commercialization Fund it draws from — while adding administrative overhead without clear evidence of improved outcomes.